| Literature DB >> 29296158 |
Abstract
Immunization for children against vaccine-preventable diseases is one of the most important health intervention method in the world, both in terms of its health impact and cost-effectiveness. Through EPI and various other programs such as the Decades of Vaccines, immunization has been improving the health of children around the world. However, this progress falls short of global immunization targets of the Global Vaccine Action Plan (GVAP). Furthermore, the African region still lags behind in immunization, and suffers from a high proportion of vaccine preventable diseases as a result. Reminders and recall for vaccination have been shown to improve health care-seeking behaviours, and have been recommended for application in routine and supplemental measles immunization activities. With mobile phones becoming more accessible in Africa, SMS vaccine reminder system has been proposed as a convenient and easily scalable way to inform caregivers of the disease and the importance of immunization, to address any concerns related to immunization safety, and to remind them of vaccination schedules and campaigns. There have been 6 published articles and 1 unpublished article on the effect of SMS reminder system for immunization in Africa. The studies done has shown that SMS vaccination reminder has led to improvements in vaccination uptakes in various metrics, whether is through the increase in vaccination coverage, decrease in dropout rates, increase in completion rate, or decrease in delay for vaccination.Entities:
Keywords: Immunization; SMS; coverage; eradication; reminder; schedule; vaccination
Mesh:
Substances:
Year: 2017 PMID: 29296158 PMCID: PMC5745941 DOI: 10.11604/pamj.supp.2017.27.3.12115
Source DB: PubMed Journal: Pan Afr Med J
Most important information from SMS-reminder for vaccination research findings in Africa
| Country | Kenya | Nigeria | Zimbabwe | Burkina Faso | Senegal | ||
|---|---|---|---|---|---|---|---|
| Author | Gibson et al. | Haji et al. | Brown et al. | Eze, Adeleye | Bangure et al. | Schlumberger et al. | Thiaw et al. |
| Year of Publication | 2017 forthcoming | 2016 | 2016 | 2015 | 2015 | 2015 | 2013 |
| Impact of SMS | Vaccination coverage increased by 4% for SMS only, and by 8% for SMS+200KES CCT | Dropout rates decreased by 13% | RI completion rate increased by 47.3% | Timely completion rate increased by 8.7% | Vaccination coverage increased by 15% at 6 wks, by 16% at 10wks and by 20% at 14 wks | Immunization completeness for pentavalent 3rd dose increased by 18% | Vitamin A supplement coverage increased by 58.9% from baseline for intervention districts |
| Experiment Type | Cluster randomized controlled trial | Intervention evaluation | Group randomized control trial | Randomized control trial | Randomized control trial | Randomized control trial | Randomized control trial |
| Total Sample Size | 2018 from 152 villages | 1116 from 3 districts | 595 from 4 LGAs | 905 from 8 health facilities | 304 from multiple clinics | 523 from 1 health center | 1137 from 6 districts |
Forthcoming article (2017) at Lancet Global Health
No full article access, information gathered only from abstract
Unpublished report by the Helen Keller Foundation
Conditional Cash Transfer
Local Government Areas
Additional information from SMS-Reminder for vaccination research findings in Africa: methods
| Country | Kenya | Nigeria | Zimbabwe | Burkina Faso | Senegal | ||
|---|---|---|---|---|---|---|---|
| Author | Gibson et al. | Haji et al. | Brown et al. | Eze, Adeleye | Bangure et al. | Schlumberger et al. | Thiaw et al. |
| Eligibility of Participants | Children aged <5 weeks who had not received 1st pentavalent vaccine | Children aged <12 months presenting for their 1st pentavalent vaccine | Children aged 0-12 wks | Children aged 0-5 years brought for routine immunization for the first or second time | Newborns of women who delivered and were residents of Kadoma City | Children at the time of their birth or at first EPI session | Children aged 2-5 months |
| Size of Control Group | 489 | 372 | N/A | 453 | 152 | 268 | 582 |
| Intervention Type (Size) | SMS only (n=476), | SMS (n=372), | SMS (n=N/A), | SMS (n=452) | SMS (n=152) | SMS (n=253) | SMS+Vitamin A Supplement health card (n=555) |
| Trial Period for Each Child | 12 months | 16 wks | N/A | 12wks or 18 wks | 14 wks | 12 months | N/A |
i. Primary Health Care Immunization Providers’ Training
12 wks trial period for children brought for routine immunization for the second time (at 6 wks) and 18 wks trial period for children brought for routine immunization for the first time (at 0 wks).
Additional information from SMS-Reminder for vaccination research findings in Africa: results
| Country | Kenya | Nigeria | Zimbabwe | Burkina Faso | Senegal | ||
|---|---|---|---|---|---|---|---|
| Author | Gibson et al. | Haji et al. | Brown et al. | Eze, Adeleye | Bangure et al. | Schlumberger et al. | Thiaw et al. |
| Primary Outcome Measure | Immunization coverage after 12 months (FIC) | Dropout rate for pentavalent 3rd dose | RI completion rate at 12 months of age | DPT3 timely completion rate | Immunization coverage at 6 wks, 10 wks and 14 wks | Immunization completeness for pentavalent 3rd dose + OPV + rotavirus | Vitamin A supplement coverage |
| Outcome Result Based on Primary Measure (intervention group) | 86% (SMS only), | 4% (SMS), | 98.6% (SMS), | 69% (SMS) | 97% at 6 wks (SMS), | 73.3% for OPV1 (SMS), 71.3% for OPV2 (SMS), 60.3% for OPV3 (SMS) | 67.7% (SMS) |
| Outcome Result Based on Primary Measure (control) | 82% | 17% | 57.30% | 60% | 82% at 6 wks, 80% at 10 wks, | 55.7% for OPV1, | 6% |
| Baseline | N/A | 13% | N/A | 58% | 74% at 6 wks, 84% at 10 wks, 74% at 14 wks | N/A | 8.8% (intervention group) 3% (control group) |
| Confidence Interval or p-value | p=0.045 (SMS only), p<0.0001 (SMS+75 KES), p<0.0001 (SMS+200KES) | CI 0.04-0.8 (SMS) | CI 1.50-1.98 (SMS), | p=0.009, | p<0.001 (SMS) | p<0.001 for OPV1 (SMS), p<0.001 for OPV2 (SMS), | N/A |
Additional information from SMS-Reminder for vaccination research findings in Africa: SMS software and protocol
| Country | Kenya | Nigeria | Zimbabwe | Burkina Faso | Senegal | ||
|---|---|---|---|---|---|---|---|
| Author | Gibson et al. | Haji et al. | Brown et al. | Eze, Adeleye | Bangure et al. | Schlumberger et al. | Thiaw et al. |
| SMS Reminder Software | Rapid SMS | Sematime | N/A | “Internet-based web-to-SMS” | N/A | N/A | Telerivet |
| Cost per Benefactor | N/A | 0.27 USD | N/A | 0.09 USD | 0.99 USD | N/A | N/A |
| SMS Schedules | 6 wks, 10 wks, 14 wks, 9 months | 10 wks, 14 wks | N/A | 6 wks, 10 wks, 14 wks | 6 wks, 10 wks, 14 wks | 2 months, 3 months, 4 months | 6 months |
| SMS per Schedule | 3 days before and 1 day before scheduled vaccination | 2 days before and on the day of the scheduled vaccination | R/R | R/R: 1 day before, 1 day after scheduled vaccination | 7 days before, 3 days before, 1 day before schedule vaccination | N/A | on the day of scheduled vaccination |
| SMS follow up after vaccination date | No | No | Yes | Yes | No, but contain follow up by phone call | No | No, but contain household follow up |
| Message Content | “Tell Mama <BABY’S FIRST NAME>> that <VACCINE NAME> vaccine is due this week. You get KES X if Baby vaccinated in next 2 weeks. <MOTIVATION- AL MESSAGE>” | N/A | N/A | “Dear client, your child is due for his/her next dose of vaccines tomorrow Tuesday 20/7/10. Kindly bring your child to Hospital X for vaccination at 8am. Please come with immunization card. Thank you.” | “Immunization protects your child against killer diseases such as polio, whooping cough,.. You are reminded that the vaccination appointment will be due in X days’ time from today.” | N/A | N/A |
Reminder and Recall system, a system that sends messages to children that missed their vaccination schedule